Table 3: Effects of myricetin on echocardiographic parameters. LVEDs: left ventricle-end-systolic diameter; LVEDd: LV-end-diastolic diameter; IVSd: end-diastolic interventricular septal thickness; IVSs: end-systolic interventricular thickness; LVPWd: end-diastolic LV posterior wall thickness; LVPWs: end-systolic LV posterior wall thickness; FS: fractional shortening; EF: LV ejection fraction. Data were presented as means ± SEM; compared with CON or M group; # compared with STZ group.

CONMSTZSTZ + M

n12121616
HR530.81 ± 20.39547.30 ± 22.88514.91 ± 19.43536.62 ± 29.74
LVEDd3.79 ± 0.0863.81 ± 0.0893.65 ± 0.1023.71 ± 0.181#
LVEDs1.86 ± 0.0701.89 ± 0.0582.33 ± 0.0812.06 ± 0.104#
IVSd0.73 ± 0.0460.73 ± 0.0350.66 ± 0.0370.70 ± 0.043#
IVSs1.22 ± 0.0981.20 ± 0.0710.94 ± 0.0101.03 ± 0.067
LVPWd0.71 ± 0.0570.68 ± 0.1380.67 ± 0.0520.71 ± 0.043
LVPWs1.29 ± 0.0701.25 ± 0.0851.09 ± 0.0951.18 ± 0.093#
EF82.11 ± 0.67981.49 ± 0.87766.72 ± 4.51376.54 ± 2.39#
FS49.93 ± 1.5950.39 ± 1.1436.13 ± 3.2644.37 ± 1.67#